Related Experiment Video
Updated: Jun 16, 2026
12:29
Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli
Published on: March 24, 2023
[Penicillin in Belgium 1945-1952]
1Rega Instituut, KU Leuven, Minderbroedersstraat 10 - B 3000 Leuven.
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|January 21, 2010
Summary
This study reconstructs Belgium's early penicillin production efforts through preserved correspondence. It highlights the collaboration between Jacques Lannoye and Piet De Somer, leading to the establishment of the RIT factory and the Rega Institute.
Area of Science:
- Medical History
- Pharmaceutical Industry
- Bacteriology
Context:
- Penicillin production was initially dominated by US companies post-WWII.
- European entrepreneurs sought to establish their own penicillin manufacturing capabilities.
- Belgian industrialist Jacques Lannoye aimed to develop local penicillin production.
Purpose:
- To reconstruct the early history of penicillin production in Belgium.
- To detail the collaboration between Jacques Lannoye and Piet De Somer.
- To document the establishment of the RIT factory and the Rega Institute.
Summary:
- The abstract details the post-WWII establishment of penicillin production in Belgium.
- It focuses on the partnership between Jacques Lannoye (Papeteries de Genval/Soprolac) and Piet De Somer (Leuven Institute of Bacteriology).
- Their collaboration resulted in the founding of the RIT (Recherche et Industrie Thérapeutiques) factory and the Rega Institute.
Impact:
- The preserved correspondence from 1947-1952 provides a detailed account of overcoming production challenges.
- This episode is significant for Belgian medical history and the growth of the pharmaceutical sector.
- The establishment of RIT and the Rega Institute fostered antibiotic and vaccine development.
Related Concept Videos
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:28History of Microbiology
Microbiology, a scientific field dedicated to the study of microorganisms, has undergone profound development since its inception in the 17th century. Its history is marked by key discoveries and technological advancements that have shaped our understanding of life at the microscopic level and transformed medicine, agriculture, and industry.Early Foundations of MicrobiologyThe early foundations of microbiology were built on groundbreaking observations and the development of pioneering...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...